199 related articles for article (PubMed ID: 24371542)
21. CRYPTOCOCCAL meningitis in a HIV negative newly diagnosed diabetic patient: a CASE report.
Owuor OH; Chege P
BMC Infect Dis; 2019 Jan; 19(1):5. PubMed ID: 30606110
[TBL] [Abstract][Full Text] [Related]
22. The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.
Meya DB; Manabe YC; Boulware DR; Janoff EN
Curr Opin Infect Dis; 2016 Feb; 29(1):10-22. PubMed ID: 26658650
[TBL] [Abstract][Full Text] [Related]
23. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
[TBL] [Abstract][Full Text] [Related]
24. Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals.
Balasko A; Keynan Y
HIV Med; 2019 Jan; 20(1):1-10. PubMed ID: 30362282
[TBL] [Abstract][Full Text] [Related]
25. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.
Parkes-Ratanshi R; Wakeham K; Levin J; Namusoke D; Whitworth J; Coutinho A; Mugisha NK; Grosskurth H; Kamali A; Lalloo DG;
Lancet Infect Dis; 2011 Dec; 11(12):933-41. PubMed ID: 21982529
[TBL] [Abstract][Full Text] [Related]
26. Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature.
Nunnari G; Gussio M; Pinzone MR; Martellotta F; Cosentino S; Cacopardo B; Celesia BM
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1555-9. PubMed ID: 23771547
[TBL] [Abstract][Full Text] [Related]
27. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
[TBL] [Abstract][Full Text] [Related]
28. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
[TBL] [Abstract][Full Text] [Related]
29. Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches.
Brienze VMS; André JC; Liso E; Louis IV
Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33514007
[TBL] [Abstract][Full Text] [Related]
30. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
32. Microevolution of Serial Clinical Isolates of
Chen Y; Farrer RA; Giamberardino C; Sakthikumar S; Jones A; Yang T; Tenor JL; Wagih O; Van Wyk M; Govender NP; Mitchell TG; Litvintseva AP; Cuomo CA; Perfect JR
mBio; 2017 Mar; 8(2):. PubMed ID: 28270580
[TBL] [Abstract][Full Text] [Related]
33. Rapid development of IRIS in the form of cryptococcal meningitis after beginning ART.
Malik A; Khan PA; Shujatullah F; Fatima N; Shameem M; Siddiqui A
Med Mycol Case Rep; 2012; 1(1):56-8. PubMed ID: 24371739
[TBL] [Abstract][Full Text] [Related]
34. New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
Temfack E; Boyer-Chammard T; Lawrence D; Delliere S; Loyse A; Lanternier F; Alanio A; Lortholary O
Curr Neurol Neurosci Rep; 2019 Oct; 19(10):81. PubMed ID: 31673881
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
36. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
Benzekri NA; Sambou JF; Ndong S; Tamba IT; Faye D; Diallo MB; Diatta JP; Faye K; Sall I; Sall F; Manga NM; Malomar JJ; Ndour CT; Hawes SE; Seydi M; Gottlieb GS
BMC Infect Dis; 2019 Mar; 19(1):261. PubMed ID: 30876400
[TBL] [Abstract][Full Text] [Related]
38. High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
Murphy RA; Hatlen TJ; Moosa MS
AIDS Res Hum Retroviruses; 2018 May; 34(5):399-403. PubMed ID: 29353491
[TBL] [Abstract][Full Text] [Related]
39. Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.
Wajanga BM; Kalluvya S; Downs JA; Johnson WD; Fitzgerald DW; Peck RN
J Int AIDS Soc; 2011 Oct; 14():48. PubMed ID: 21988905
[TBL] [Abstract][Full Text] [Related]
40. Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome(IRIS): Pathogenesis and Its Clinical Implications.
Wiesner DL; Boulware DR
Curr Fungal Infect Rep; 2011 Dec; 5(4):252-261. PubMed ID: 22389746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
